JINZANGHUANG TIBET PHARMACEUTICALS, INC. - FORM 10-K - EX-32 - RULE 13A-14(B) CERTIFICATIONS - October 13, 2011

Attached files

file filename
10-K - JINZANGHUANG TIBET PHARMACEUTICALS, INC. FORM 10-K JUNE 30, 2011 - JINZANGHUANG TIBET PHARMACEUTICALS, INC.jzhg10-k20110630.htm
EX-31.1 - RULE 13A-14(A) CERTIFICATION - CEO - JINZANGHUANG TIBET PHARMACEUTICALS, INC.ex311.htm
EX-31.2 - RULE 13A-14(A) CERTIFICATION - CFO - JINZANGHUANG TIBET PHARMACEUTICALS, INC.ex312.htm
EX-10.D - AMENDED AND RESTATED PROXY AGREEMENT DATED JULY 24, 2009 AMONG BEIJING TAIBODEKANG CO., LTD., THE EQUITY OWNERS IN LELING JINZANGHUANG BIOTECH CO., LTD., AND LELING JINZANGHUANG BIOTECH CO., LTD. - JINZANGHUANG TIBET PHARMACEUTICALS, INC.ex10-d.htm
EX-10.B - AMENDED AND RESTATED SHARE PLEDGE AGREEMENT DATED JULY 24, 2009 AMONG BEIJING TAIBODEKANG CO., LTD., THE EQUITY OWNERS IN LELING JINZANGHUANG BIOTECH CO., LTD. AND LELING JINZANGHUANG BIOTECH CO., LTD. - JINZANGHUANG TIBET PHARMACEUTICALS, INC.ex10-b.htm
EX-10.C - AMENDED AND RESTATED CALL OPTION AGREEMENT DATED JULY 24, 2009 AMONG BEIJING TAIBODEKANG CO., LTD. AND THE EQUITY OWNERS IN LELING JINZANGHUANG BIOTECH CO., LTD. - JINZANGHUANG TIBET PHARMACEUTICALS, INC.ex10-c.htm
 
EXHIBIT 32

 
Rule 13a-14(b) Certifications
 
 
The undersigned officers certify that this report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and that the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of Jinzanghuang Tibet Pharmaceuticals, Inc.
 
A signed original of this written statement required by Section 906 has been provided to Jinzanghuang Tibet Pharmaceuticals, Inc. and will be retained by Jinzanghuang Tibet Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
 
October 13, 2011
/s/ Xue Bangyi                                      
 
Xue Bangyi (Chief Executive Officer)
   
October 13, 2011
/s/ Eva Deng                                     
 
Eva Deng (Chief Financial Officer)
 

JINZANGHUANG TIBET PHARMACEUTICALS, INC. Reports